A mong modifiable risk factors associated with cardiovascular diseases, systemic hypertension is the leading one in terms of risk for mortality, responsible for 13% of deaths globally. 1 In 2009, the cost of antihypertensive treatment to the Quebec government alone was $589 million. 2 The importance of this risk factor for heart, renal and vascular diseases is well known, which is why population studies are essential to assess its prevalence over time. It was recently demonstrated using administrative databases all over Canada, that nearly 6 million Canadians aged ≥20 years were hypertensive in [2007][2008] The three sources of data have their strengths and limitations. Administrative databases contain data for all Quebecers and are continually updated, however they tend to concentrate on those who are diagnosed and actively consulting physicians, and they under-report hypertension in the presence of other diseases. Survey data estimate either self-reported diagnosed or measured hypertension, the latter being expensive and limited to a few representative people, especially with direct physical measures. The aim of this study was to compare the prevalence of hypertension using both sources of data, in the province of Quebec. We also concentrated our comparison on people at higher risk, i.e., the elderly population. The levels of hypertension awareness, treatment and control were also assessed with the CHMS since it combined information on direct measurements with self-reported diagnosis and treatment.
diagnosis of hypertension. It consists of five linked administrative databases with records dating from January 1, 1996 and updated annually; two of the databases were used for this study: 1) the physician billing database from the Régie de l'assurance maladie du Québec (RAMQ), and 2) the hospitalization database. The first database includes all procedures billed to the RAMQ, while the second is referring to the principal diagnosis and up to 15 or 25 secondary diagnoses associated with hospitalization stays, depending on whether the stay came before or after April 1, 2006 . In both databases, the International Classification of Diseases (ICD) was used; dating from April 1, 2006 , the 10 th ICD version was used in the hospitalization database. Demographics and geographical data such as age, sex, postal code and date of death as well as information on eligibility for health insurance were obtained from the register of insured persons (FIPA). In addition, the death file was used for information on the causes of death (coded in ICD-10 since January 1, 2000) . The denominator for calculating the rate was determined according to 2006 Canadian census data, specifically population estimates for 2000 to 2005 and population projections for 2006 and over.
Canadian Health Measures Survey
The CHMS is a cross-sectional survey from Statistics Canada that aims to collect important health information through a household interview followed by direct physical measurements at a mobile laboratory centre for individuals aged between 6 and 79 years living in privately occupied dwellings in the 10 provinces and the 3 territories of Canada. Full-time members of the Canadian Forces, and residents of Crown lands or Indian reserves, institutions and certain remote regions were excluded. 6 The collection sites were created using the Labour Force Survey's area frame, grouped as well with respect to provincial and census metropolitan-area boundaries and population density criteria. Sites were then randomly selected using a systematic sampling method with probability proportional to the size of each site's population. Four representative sites in Quebec were interviewed in each cycle (cycle 1: 2007-2009, cycle 2: 2009-2011 ). Blood pressure (BP) on the right arm was measured 6 times at oneminute intervals, in the sitting position, following a 5-minute rest period according to a protocol created by the CHMS. 7 Measurements were taken using an oscillometric BP measurement automated electronic device and the last 5 measurements were used. 4, 8 In the household interview, respondents were asked questions consistent with those in other Statistics Canada health surveys: "Do you have high BP?" (diagnosed by a health professional) and "In the past month, have you taken any medicine for high BP?" Pregnant women and people aged between 6 and 19 years were excluded from our analysis.
Definitions

Administrative Databases
To be considered hypertensive, an individual aged ≥20 years should be eligible for health insurance in Quebec, and have either ≥2 diagnoses of hypertension on the physician billing database within a two-year period, or 1 diagnosis (primary or secondary) of hypertension recorded in the hospitalization database. 3 The following diagnostic codes were used: 401 to 405 for ICD-9 and I10 to I13 and I15 for ICD-10. In order to exclude cases of gestational hypertension, all hypertension diagnoses for women aged 20 to 54 years recorded in a window 120 days before or 180 days after any obstetrical-related hospital admission were not considered. Diagnostic codes used to identify these events were: 641 to 676 and V27 for ICD-9, and O10-O19, O21-O95, O98, O99 and Z37 for ICD-10. This case definition has been validated in three Canadian provinces with sensitivity of 66-72% and specificity of 95-97%. 9, 10 The observation period used runs from January 1, 1996 to March 31, 2010. However, a minimum of four years is necessary to distinguish incident cases from prevalent cases diagnosed before January 1996. Thus, measures are presented from 2000-2001.
Canadian Health Measures Survey
Hypertension was defined as an average measured systolic or diastolic blood pressure (SBP/DBP) ≥140/90 mm Hg or selfreported use of BP-lowering medication in the last month. Awareness of hypertension was defined as a self-report of either medically diagnosed hypertension or BP medication use in the past month. 4 Treatment of hypertension was defined as the selfreported use of BP-lowering medication within the last month. BP control was reported as an average currently treated (with medication) SBP/DBP <140/90 mm Hg. The three latter measures were calculated among all those with hypertension.
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Statistical analysis
Prevalence, incidence and mortality using administrative databases were calculated as in Robitaille et Prevalence per 100
Fiscal year
rates by the rate of the first year multiplied by 100. The relative difference between sexes is obtained by dividing the difference in rates by the one from men multiplied by 100. Regarding the CHMS, frequencies and means were produced to estimate the prevalence of hypertension, distribution of BP, awareness, treatment, and control by using the combined sampling weights from both cycles. Bootstrap techniques and Student t distribution (with 6 degrees of freedom for Quebec data) were used to calculate the 95% confidence intervals of estimates and the statistical t test on differences between estimates. Statistical analyses were performed with SAS Enterprise Guide version 5.1 (Cary, NC, USA). P-values <0.05 were considered significant.
RESULTS
Administrative data
Prevalence Figure 1B ). In people aged ≥65 years, there is also a higher incidence among women, but in the final year, the incidence among men reached a comparable level.
Mortality
As shown in Figure 1C , and men (81.1%); p>0.5. As the prevalence of hypertension increases with age (60.4% in people aged 65-79 years), so does the awareness (89.3%). As shown in Table 2 , treatment of hypertension was 83.1% and was similar between women and men (86.8% vs. 79.4%, p>0.25). Almost 70% had their BP controlled and this was similar between men and women.
Causes of death
As shown in Figure 3 
DISCUSSION
This is the first study comparing hypertension prevalence in the province of Quebec using different sources of data. For people aged 20-79 years, the prevalence determined via administrative database (20.2%) is comparable to the one auto-declared (20.9%) while the measurement/medication was 23.1%. This is also the first study that estimated trends in hypertension prevalence, incidence and mortality in Quebec. Using the most recent administrative data, hypertension was diagnosed in approximately 1,433,400 individuals aged ≥20 years in 2009-2010 in the province of Quebec (23.6%). Globally, though the prevalence of diagnosed hypertension is increasing (a rise of 32% in the last decade), both incidence and mortality are decreasing (27% and 16%, respectively). The difference between men and women for the year 2009-2010 in the prevalence (+12% for women) and mortality (-14% for women) of hypertension was most important for patients aged ≥65 years. In fact, the prevalence of hypertension in elderly women was 69.0%, making this a very high-risk subgroup. Awareness, treatment and control of hypertension are very high in Quebec.
The relatively lower prevalence of hypertension in the administrative data compared to the measurement/medication use can be explained because hypertension is often asymptomatic and a small proportion of people could have discovered their hypertension at the mobile laboratory. This is especially true since the prevalence of the auto-declared hypertension is almost the same as that of the administrative data. However, a recent study demonstrated that in Canada, even if the prevalence of hypertension determined through the CHMS and the administrative data were similar, the one obtained with administrative data was 20.3% compared to 19.5% for the CHMS in 2007-2009. 5 Nevertheless, both studies found that autodeclared hypertension was the lowest. Our prevalence was lower than those found in other developed countries such as England (33%), Denmark (26%), China (36%) and United States (30%). [11] [12] [13] [14] Higher prevalence of hypertension in elderly women was also reported in China and Spain. 13, 15 Of note, the increase in prevalence of hypertension observed herein is higher than the one projected by Kearney et al. 16 of 24% for developed countries between 2000 and 2025.
Awareness of hypertension (84.3%) was higher compared to many countries, such as China (43%), United States (74%), Finland (68%) and Denmark (72%). 13 and 57% in Denmark). 11 In fact, these results are comparable to those obtained in a different survey from our Ontario neighbours, 19 which reported the highest population rates for drug treatment and control of hypertension worldwide. These high rates are compatible with the results of Gee et al. who reported that most Canadians diagnosed with hypertension are taking antihypertensive medications and are reporting adherence. 20 Since Canada has been recognized as a world leader in the prevention, treatment and control of hypertension, it is interesting to emphasize that Quebec, the country's secondlargest province, is also observing these high rates. 4, 21 Furthermore, when looking at the population-adjusted number of antihypertensive prescriptions in 2006, Quebec had the greatest number (42,877 per 10,000 people) and was above the average Canadian level (26, 486) . 22 Moreover, most Canadians with diagnosed hypertension are reporting sustained lifestyle modification to control their hypertension, such as limiting salt consumption (89%), changing the types of food they eat (89%), engaging in physical activity (80%), etc. 23 The greater awareness, treatment and control found in Quebecers can be seen in light of the introduction, in 1999, of the Canadian Hypertension Education Program (CHEP), an extensive national knowledge translation strategy for professionals to improve hypertension management. 21, 24, 25 This program has increased the diagnosis and treatment of hypertension and is viewed as an international model regarding knowledge translation. [26] [27] [28] Moreover, another study demonstrated that 46% of Canadian adults with hypertension are monitoring their BP at home, explaining in part these high numbers. 29 The decrease in cardiovascular deaths between 2000 and 2007 (22%) could also be seen to be a result of this program. Nonetheless, the majority of the people with diagnosed hypertension who died did so as a result of coronary heart disease (CHD: 16.4%), while stroke (3.8%) was the fifthleading cause. These results are in agreement with those of Arima et al., underlying that CHD causes most cardiovascular deaths among hypertensive Caucasian populations of the "Western world".
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Limitations
The prevalence of hypertension might have been underestimated because of the elderly population not surveyed or those living in nursing homes or other institutions not captured in either administrative or survey data. Provincial representativeness of the collection sites in Quebec produced with the CHMS may not be optimal since the sample design was nationally done. People who achieved BP control by non-pharmacological means, such as dietary and lifestyle modification, are not included, resulting in an underestimation of the "real" hypertension prevalence and control in the survey. Even when BP was measured 6 times following a standard protocol, this was performed during only a single visit. Self-reported information, particularly on the use of BP medications, might be subject to misunderstanding and/or recall bias. Information on neither dosage nor compliance are available in the survey. Statistical power is another limitation of the CHMS, especially when comparing sexes and age subgroup. Administrative data are only capturing people in contact with the health care system, and in the case of multiple associated comorbidities, such as diabetes, hypertension would not be the first diagnosis in the physician billing database. As 75% of patients with diabetes also have hypertension, this can be a frequent situation. 31 Finally, the time comparison of hypertension prevalence between administrative and survey data was not exactly the same.
Although the prevalence of diagnosed hypertension has increased in the province of Quebec, this could be attributable in Prevalence per 100
Age group * part to a decrease in mortality and not to an increased incidence since the latter is decreasing. It is noteworthy to underline that the highest prevalence of hypertension, i.e., in elderly women, is increasing dramatically over time, while their mortality is lower compared to men. The level of awareness, treatment and control of hypertension in Quebec is one of the highest in the world. More importantly, the prevalence of hypertension obtained with administrative data is comparable to that obtained with the measurement/medication from a survey and should be used, especially to examine the burden of cardiovascular diseases in Quebec, where it is accessible, continually updated and this at a low cost and for all people, whatever their age or socio-economic status. Moreover, these linked databases allow the determination of incidence, mortality and drug consumption. Even with the strong agreement between administrative and survey data, future directions should include linking the CHMS with the QICDSS using the personal health insurance number. This linkage will allow comparison of cases identified in the CHMS with those identified using administrative data. These results on prevalence, awareness and control of hypertension are important for clinical care, health care and public health planning, and underline the need to reduce the burden of this silent killer, especially among elderly people. 
